☰

Martin Kay - Publications

Affiliations: 
Linguistics Stanford University, Palo Alto, CA 
Tree Info Similar researchers PubMed Report error

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2006 Hebert ML, Grimm D, Storm TA, Kay MA. 489. Treatment for Hemophilia B Using Self- Complimentary AAV8 Vectors Molecular Therapy. 13: S189-S190. DOI: 10.1016/J.Ymthe.2006.08.559  0.316
2006 Grimm D, Streetz KL, Storm TA, Jopling CL, Lee JS, Kay MA. 805. Fatality in Mice Due to Oversaturation of Cellular Micro/Short Hairpin RNA Pathways Molecular Therapy. 13. DOI: 10.1016/J.Ymthe.2006.08.1226  0.309
2005 Ehrhardt A, Kay MA. Gutted adenovirus: a rising star on the horizon? Gene Therapy. 12: 1540-1. PMID 18360947 DOI: 10.1038/Sj.Gt.3302597  0.312
2005 Grimm D, Pandey K, Streetz KL, Kay MA. 857. A Versatile and Efficient Viral Vector Platform for Stable In Vivo Expression of Short Hairpin RNA Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.400  0.312
2005 Grimm D, Streetz KL, Pandey K, Storm TA, Kay MA. 87. Determinants of Toxicity Induced by In Vivo Expression of Short Hairpin RNA from AAV Vectors Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.065  0.31
2005 Mikkelsen JG, Yant SR, Ehrhardt A, Kay MA. 22. Generation of Circular Sleeping Beauty DNA Transposition Substrates by RU486-Induced Flp Recombination In Vitro |[ndash]| Steps towards a Single Integrating Adeno-Transposon Vector Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.025  0.306
2004 Riu E, Huang Z, Kay MA. 1039. Mechanistic Insights into the Persistence of Non-Viral Mediated Gene Transfer In Vivo Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.984  0.305
2003 Mikkelsen JG, Yant SR, Meuse L, Huang Z, Xu H, Kay MA. Helper-Independent Sleeping Beauty transposon-transposase vectors for efficient nonviral gene delivery and persistent gene expression in vivo. Molecular Therapy : the Journal of the American Society of Gene Therapy. 8: 654-65. PMID 14529839 DOI: 10.1016/S1525-0016(03)00216-8  0.304
2003 Sclimenti CR, Neviaser AS, Baba EJ, Meuse L, Kay MA, Calos MP. Epstein-Barr virus vectors provide prolonged robust factor IX expression in mice Biotechnology Progress. 19: 144-151. PMID 12573017 DOI: 10.1021/Bp0200907  0.323
2002 Yant SR, Ehrhardt A, Mikkelsen JG, Meuse L, Pham T, Kay MA. Transposition from a gutless adeno-transposon vector stabilizes transgene expression in vivo. Nature Biotechnology. 20: 999-1005. PMID 12244327 DOI: 10.1038/Nbt738  0.317
2001 Stoll SM, Sclimenti CR, Baba EJ, Meuse L, Kay MA, Calos MP. Epstein-Barr virus/human vector provides high-level, long-term expression of α1-antitrypsin in mice Molecular Therapy. 4: 122-129. PMID 11482983 DOI: 10.1006/Mthe.2001.0429  0.303
2000 Nakai H, Storm TA, Kay MA. Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectors Nature Biotechnology. 18: 527-532. PMID 10802620 DOI: 10.1038/75390  0.301
2000 Miao CH, Nakai H, Thompson AR, Storm TA, Chiu W, Snyder RO, Kay MA. Nonrandom transduction of recombinant adeno-associated virus vectors in mouse hepatocytes in vivo: cell cycling does not influence hepatocyte transduction. Journal of Virology. 74: 3793-803. PMID 10729154 DOI: 10.1128/Jvi.74.8.3793-3803.2000  0.318
1998 Patijn GA, Lieber A, Meuse L, Winther B, Kay MA. High-efficiency retrovirus-mediated gene transfer into the livers of mice. Human Gene Therapy. 9: 1449-56. PMID 9681416 DOI: 10.1089/Hum.1998.9.10-1449  0.311
Show low-probability matches.